Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterResearch Letter

Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series

Karmela K. Chan, Nilasha Ghosh, Carlos Aude, Edward DiCarlo and Anne R. Bass
The Journal of Rheumatology November 2025, jrheum.2025-0696; DOI: https://doi.org/10.3899/jrheum.2025-0696
Karmela K. Chan
K.K. Chan, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, New York, USA; Division of Rheumatology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karmela K. Chan
Nilasha Ghosh
N. Ghosh, MD, MS, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, New York, USA; Division of Rheumatology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nilasha Ghosh
Carlos Aude
C. Aude, BA, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Aude
Edward DiCarlo
E. DiCarlo, MD, Department of Pathology, Hospital for Special Surgery, New York, New York, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward DiCarlo
Anne R. Bass
A.R. Bass, MD, Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, New York, USA; Division of Rheumatology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne R. Bass
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Plain Language Summary

This is a case series of 16 patients with cancer who were treated with immune checkpoint inhibitor (ICI) therapy and who underwent 23 joint replacements. Some of these patients were known to have inflammatory arthritis (joint inflammation) as a side effect of the ICI therapy, whereas others were thought to have worsening of established osteoarthritis (OA). We wanted to know whether the patients with OA had ICI-related joint inflammation that was simply not recognized before surgery. We also wanted to know whether patients who undergo joint replacements on ICI have more surgery complications than other people. What we found was that the people who were diagnosed with OA prior to surgery had OA on joint histology. Only the patients with known inflammatory arthritis from ICI had significant inflammation on joint histology. One patient required a revision of her hip joint replacement 3.7 years after surgery (while still on ICI) due to an inflammatory reaction to her joint replacement. We could not determine whether ICI played a role in that complication.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (12)
The Journal of Rheumatology
Vol. 52, Issue 12
1 Dec 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series
Karmela K. Chan, Nilasha Ghosh, Carlos Aude, Edward DiCarlo, Anne R. Bass
The Journal of Rheumatology Nov 2025, jrheum.2025-0696; DOI: 10.3899/jrheum.2025-0696

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series
Karmela K. Chan, Nilasha Ghosh, Carlos Aude, Edward DiCarlo, Anne R. Bass
The Journal of Rheumatology Nov 2025, jrheum.2025-0696; DOI: 10.3899/jrheum.2025-0696
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Racial and Ethnic Disparities in Disease-Modifying Antirheumatic Drug Use Among Adults With Rheumatoid Arthritis in the United States
  • Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study
Show more Research Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire